212 related articles for article (PubMed ID: 15562021)
1. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
J Clin Endocrinol Metab; 2005 Feb; 90(2):800-4. PubMed ID: 15562021
[TBL] [Abstract][Full Text] [Related]
2. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
Brada M; Ford D; Ashley S; Bliss JM; Crowley S; Mason M; Rajan B; Traish D
BMJ; 1992 May; 304(6838):1343-6. PubMed ID: 1611331
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Ubachs DH; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Mar; 100(3):1104-12. PubMed ID: 25574793
[TBL] [Abstract][Full Text] [Related]
4. The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone.
Sattler MG; van Beek AP; Wolffenbuttel BH; van den Berg G; Sluiter WJ; Langendijk JA; van den Bergh AC
Radiother Oncol; 2012 Jul; 104(1):125-30. PubMed ID: 22682541
[TBL] [Abstract][Full Text] [Related]
5. Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden.
Norberg L; Johansson R; Rasmuson T
Acta Oncol; 2010 Nov; 49(8):1276-82. PubMed ID: 20429723
[TBL] [Abstract][Full Text] [Related]
6. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas.
Brada M; Rajan B; Traish D; Ashley S; Holmes-Sellors PJ; Nussey S; Uttley D
Clin Endocrinol (Oxf); 1993 Jun; 38(6):571-8. PubMed ID: 8334743
[TBL] [Abstract][Full Text] [Related]
7. The incidence of cerebrovascular accidents in patients with pituitary adenoma.
Brada M; Burchell L; Ashley S; Traish D
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):693-8. PubMed ID: 10524424
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.
Norberg L; Johansson R; Rasmuson T
Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004
[TBL] [Abstract][Full Text] [Related]
9. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk.
Tsang RW; Laperriere NJ; Simpson WJ; Brierley J; Panzarella T; Smyth HS
Cancer; 1993 Oct; 72(7):2227-33. PubMed ID: 8374881
[TBL] [Abstract][Full Text] [Related]
10. External radiotherapy of pituitary adenomas.
Zierhut D; Flentje M; Adolph J; Erdmann J; Raue F; Wannenmacher M
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):307-14. PubMed ID: 7673017
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy of pituitary adenomas: state of the art.
Gilliot O; Khalil T; Irthum B; Zasadny X; Verrelle P; Tauveron I; Pontvert D
Ann Endocrinol (Paris); 2007 Oct; 68(5):337-48. PubMed ID: 17512895
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety of growth hormone replacement after CNS irradiation.
Mackenzie S; Craven T; Gattamaneni HR; Swindell R; Shalet SM; Brabant G
J Clin Endocrinol Metab; 2011 Sep; 96(9):2756-61. PubMed ID: 21715535
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiotherapy for the treatment of pituitary adenomas.
Selch MT; Gorgulho A; Lee SP; Mattozo C; Solberg TD; Agazaryan N; Desalles AA
Minim Invasive Neurosurg; 2006 Jun; 49(3):150-5. PubMed ID: 16921455
[TBL] [Abstract][Full Text] [Related]
15. Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma.
Winkfield KM; Niemierko A; Bussiere MR; Crowley EM; Napolitano BN; Beaudette KP; Loeffler JS; Shih HA
Technol Cancer Res Treat; 2011 Jun; 10(3):243-51. PubMed ID: 21517130
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
Jalali R; Brada M; Perks JR; Warrington AP; Traish D; Burchell L; McNair H; Thomas DG; Robinson S; Johnston DG
Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 10848873
[TBL] [Abstract][Full Text] [Related]
17. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of 68 patients with pituitary adenoma treated by radiotherapy].
Hu CS; Ying HM; Shen CY
Ai Zheng; 2002 Oct; 21(10):1154-7. PubMed ID: 12508665
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for pituitary adenomas: long-term efficacy and toxicity.
Erridge SC; Conkey DS; Stockton D; Strachan MW; Statham PF; Whittle IR; Grant R; Kerr GR; Gregor A
Radiother Oncol; 2009 Dec; 93(3):597-601. PubMed ID: 19900729
[TBL] [Abstract][Full Text] [Related]
20. [Malignant astrocytoma following radiotherapy in pituitary adenoma: case report].
Suda Y; Mineura K; Kowada M; Ohishi H
No Shinkei Geka; 1989 Aug; 17(8):783-8. PubMed ID: 2685639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
